Apollo Endosurgery Incの価格/簿価
Apollo Endosurgery Incの価格/簿価は何ですか。
Apollo Endosurgery Incの価格/簿価は12.01です。
価格/簿価の定義は何ですか。
株価純資産倍率は、会社の株価と1株当たりの簿価との比率を表します。
The price to book ratio, or P/B ratio, is a financial ratio used to compare a company's current market price to its book value. It is also sometimes known as a market to book ratio or price to equity ratio. The calculation of a price to book ratio can be performed in two ways. It can be calculated as the company's market capitalization divided by the company's total book value from its balance sheet. It can also be calculated using per-share values and dividing a company's current share price by the book value per share (i.e. its book value divided by the number of outstanding shares).
The P/B ratio varies between industries. The industries that require more infrastructure capital (for each dollar of profit) will usually trade at P/B ratios much lower than, for example, consulting firms. P/B ratios are commonly used to compare banks, because most assets and liabilities of banks are constantly valued at market values. A higher P/B ratio implies that investors expect management to create more value from a given set of assets, all else equal (and/or that the market value of the firm's assets is significantly higher than their accounting value).
P/B ratios do not, however, directly provide any information on the ability of the firm to generate profits or cash for shareholders. This ratio also gives some idea of whether an investor is paying too much for what would be left if the company went bankrupt immediately. For companies in distress, the book value is usually calculated without the intangible assets that would have no resale value. In such cases, P/B should also be calculated on a "diluted" basis, because stock options may well vest on sale of the company or change of control or firing of management.
NASDAQのセクタHealth Careにおける価格/簿価の企業と比べるApollo Endosurgery Inc
Apollo Endosurgery Incは何をしますか。
Apollo Endosurgery, Inc. is a medical technology company focused on less invasive therapies to treat various gastrointestinal conditions, ranging from gastrointestinal defect repairs to the interventional treatment of obesity. Apollo's device-based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo's products are offered in over 75 countries today and include the X-Tack™ Endoscopic HeliX Tacking System, the OverStitch™ Endoscopic Suturing System, the OverStitch Sx™ Endoscopic Suturing System, and the ORBERA® Intragastric Balloon.
Apollo Endosurgery Incと類似の価格/簿価
- IFB Industriesの価格/簿価は11.94です。
- INEO Techの価格/簿価は11.95です。
- Foseco Indiaの価格/簿価は11.95です。
- Atari SAの価格/簿価は11.96です。
- Aditya Birla Moneyの価格/簿価は11.98です。
- Manitou Goldの価格/簿価は12.01です。
- Apollo Endosurgery Incの価格/簿価は12.01です。
- UET United Electronic Technology AGの価格/簿価は12.01です。
- Vesuvius Indiaの価格/簿価は12.01です。
- Norwest NLの価格/簿価は12.03です。
- Genesys Internationalの価格/簿価は12.03です。
- Relx Plcの価格/簿価は12.04です。
- Qualys Incの価格/簿価は12.05です。